What is the current stock price of Spectral AI, Inc. (MDAI)?

As of the latest market data, Spectral AI, Inc. (MDAI) is trading at $1.73. The stock has seen a gain of 3.59% today.

Does Spectral AI, Inc. (MDAI) pay a dividend?

Based on current data, Spectral AI, Inc. does not have a confirmed active dividend policy.

What is the market cap of Spectral AI, Inc.?

The current market capitalization of Spectral AI, Inc. (MDAI) is approximately unavailable.

MDAI

Spectral AI, Inc.·Healthcare

1.73

3.593%(+0.06)

Market Closed

1.76

1.734%(+0.03)

After Hours

Last Updated: — ET

52W L: $1.1352W H: $3.21

MDAI NEWS

globenewswire.com

2d ago

Spectral AI to Feature DeepView® System at 2026 American Burn Association Annual Meeting

DALLAS, April 09, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its participation in the upcoming Annual Meeting of the American Burn Association, being held April 14-17, 2026 in Orlando, Florida. The Company's DeepView® System will be on display at Booth 601.

globenewswire.com

3d ago

Spectral AI Names David McGuire, CPA, as Chief Financial Officer

DALLAS, April 08, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the appointment of David McGuire as the Company's Chief Financial Officer, effective May 4, 2026.

defenseworld.net

Mar 28

Reviewing ADM Tronics Unlimited (OTCMKTS:ADMT) & Spectral AI (NASDAQ:MDAI)

Spectral AI (NASDAQ: MDAI - Get Free Report) and ADM Tronics Unlimited (OTCMKTS:ADMT - Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk. Analyst Ratings This is a breakdown

defenseworld.net

Mar 26

Spectral AI Q4 Earnings Call Highlights

Spectral AI (NASDAQ: MDAI) executives said fiscal 2025 marked a "pivotal year" as the company advanced its DeepView burn diagnostic system toward potential FDA clearance and strengthened its funding profile, highlighted by a new award under its longstanding BARDA partnership. DeepView FDA path and clinical data Chief Executive Officer Vincent Capone said the company's June 2025

defenseworld.net

Mar 25

Spectral AI (MDAI) to Release Quarterly Earnings on Wednesday

Spectral AI (NASDAQ: MDAI - Get Free Report) is expected to announce its Q4 2025 results after the market closes on Wednesday, April 1st. Analysts expect the company to announce earnings of ($0.12) per share and revenue of $2.9230 million for the quarter. Investors may visit the the company's upcoming Q4 2025 earning results page for

seekingalpha.com

Mar 24

Spectral AI, Inc. (MDAI) Q4 2025 Earnings Call Transcript

Company Profile

Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.

Sector

Healthcare

Industry

Medical - Devices

Employees

IPO Date

2021-04-06

Beta

0.91

Websitewww.spectral-ai.com↗